Internal Medicine, Gastroenterology · Boston, MA
NPI
1285661652
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
133 Brookline Ave Fl 9
Boston, MA, 02215
Phone (617) 421-1091
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
3,136 services
Medicare patients, 2024
239
Average age 73
Drug cost, 2024
$268K
1,251 prescriptions
Company payments, 2023
$36.69
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James C Chou was code 45380 (lower gi endoscopy - other), 67 times for 67 patients. In total James C Chou billed 3,136 services in 61 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Office | 67 | 67 | $320.30 | $21K |
| 99214 Office E&M - Established | Office | 63 | 61 | $100.61 | $6,338 |
| 36415 Venipuncture Blood Collection | Office | 62 | 33 | $8.65 | $536 |
| 85027 Blood Count | Office | 60 | 28 | $6.34 | $380 |
| 82565 Clinical Chemistry | Office | 46 | 23 | $5.02 | $231 |
| 80076 Clinical Chemistry | Office | 40 | 19 | $8.01 | $320 |
| 83540 Clinical Chemistry | Office | 37 | 17 | $6.34 | $235 |
| 84466 Clinical Chemistry | Office | 37 | 17 | $12.50 | $463 |
| 45385 Colonoscopy - Lesion Removal | Office | 35 | 35 | $392.59 | $14K |
| 99213 Office E&M - Established | Office | 29 | 26 | $73.45 | $2,130 |
| 82105 Clinical Chemistry | Office | 28 | 12 | $16.43 | $460 |
| 43239 Upper GI Endoscopy | Office | 27 | 27 | $228.75 | $6,176 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 21 | 21 | $295.66 | $6,209 |
| 82948 Clinical Chemistry | Office | 19 | 18 | $4.94 | $93.86 |
By year: 2022 $123K for 1,704 services; 2023 $118K for 1,778 services; 2024 $113K for 3,136 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 62 | 33 | $8.65 | $536 |
| 85027 Blood Count | 60 | 28 | $6.34 | $380 |
| 82565 Clinical Chemistry | 46 | 23 | $5.02 | $231 |
| 80076 Clinical Chemistry | 40 | 19 | $8.01 | $320 |
| 83540 Clinical Chemistry | 37 | 17 | $6.34 | $235 |
| 84466 Clinical Chemistry | 37 | 17 | $12.50 | $463 |
| 82105 Clinical Chemistry | 28 | 12 | $16.43 | $460 |
| 82948 Clinical Chemistry | 19 | 18 | $4.94 | $93.86 |
Medicare prescription drug claims, 2024
In 2024, the drug James C Chou prescribed most often to Medicare patients was Omeprazole, with 205 prescriptions and refills. In total James C Chou wrote 1,251 Medicare prescriptions that cost $268K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 205 | 560 | 76 | $4,691 |
| Famotidine Generic | 177 | 462 | 66 | $3,516 |
| Pantoprazole Sodium Generic | 119 | 255 | 34 | $2,370 |
| Lansoprazole Generic | 106 | 210 | 28 | $2,273 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 87 | 87 | 86 | $1,478 |
| Linzess Linaclotide | 77 | 111 | 19 | $58K |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 70 | 70 | 69 | $4,404 |
| Sucralfate Generic | 56 | 93 | 18 | $4,744 |
| Mesalamine Generic | 24 | 49 | Under 11 | $36K |
| Trulance Plecanatide | 23 | 27 | Under 11 | $15K |
| Esomeprazole Magnesium Generic | 22 | 42 | Under 11 | $1,961 |
| Dicyclomine Hcl Generic | 21 | 31 | Under 11 | $538 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 21 | 21 | 20 | $1,284 |
| Entecavir Generic | 20 | 36 | Under 11 | $2,954 |
| Mesalamine Er Mesalamine | 14 | 20 | Under 11 | $2,196 |
Brand drugs: 207 claims; generic drugs: 1,044 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid James C Chou $36.69 ($36.69 in general payments such as food, travel and fees) from 1 company. The largest payer was Teva Pharmaceuticals USA, Inc. with $36.69.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $36.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.